Korean J Transplant.  2023 Dec;37(4):310-312. 10.4285/kjt.23.0050.

Sirolimus-induced leukocytoclastic vasculitis

• Ramteke V
• Pattewar S
• Barde N
• Deshpande N

• KMID: 2550244
• DOI: http://doi.org/10.4285/kjt.23.0050

Figure

• 

  Fig. 1 (A, B) Image showing non-pruritic ulcerative lesions with scales over the great and little toes.

• 

  Fig. 2 (A, B) Image showing resolution of the skin lesions with residual hyperpigmentation on the great and little toes after discontinuing sirolimus.

Reference

1. Fiorentino DF. 2003; Cutaneous vasculitis. J Am Acad Dermatol. 48:311–40. DOI: 10.1067/mjd.2003.212. PMID: 12637912.

2. Hardinger KL, Cornelius LA, Trulock EP 3rd, Brennan DC. 2002; Sirolimus-induced leukocytoclastic vasculitis. Transplantation. 74:739–43. DOI: 10.1097/00007890-200209150-00025. PMID: 12352895.

3. Pasqualotto AC, Bianco PD, Sukiennik TC, Furian R, Garcia VD. 2004; Sirolimus-induced leukocytoclastic vasculitis: the second case reported. Am J Transplant. 4:1549–51. DOI: 10.1111/j.1600-6143.2004.00513.x. PMID: 15307846.